Report

Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer

See allHide authors and affiliations

Science  14 Sep 2017:
eaao3130
DOI: 10.1126/science.aao3130

Log in to view full text

Log in through your institution

Log in through your institution

Subjects

Navigate This Article